Cargando…

Research and development of Chinese anti-COVID-19 drugs

The outbreak and spread of coronavirus disease 2019 (COVID-19) highlighted the importance and urgency of the research and development of therapeutic drugs. Very early into the COVID-19 pandemic, China has begun developing drugs, with some notable progress. Herein, we summarizes the anti-COVID-19 dru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Xiwei, Meng, Xiangrui, Zhu, Xiao, He, Qingfeng, Cui, Yimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472487/ https://www.ncbi.nlm.nih.gov/pubmed/36119967 http://dx.doi.org/10.1016/j.apsb.2022.09.002

Ejemplares similares

Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF Signaling
por: Ji, Xiwei, et al.
Publicado: (2023)

Progress in the Research and Development of Anti-COVID-19 Drugs
por: Huang, Lianzhou, et al.
Publicado: (2020)

Development and Research Progress of Anti-Drug Resistant Bacteria Drugs
por: Cui, Xiangyi, et al.
Publicado: (2021)

Potential herb–drug interactions between anti-COVID-19 drugs and traditional Chinese medicine
por: Ye, Ling, et al.
Publicado: (2023)

Research progress of anti-glioma chemotherapeutic drugs
por: Zhou, Yi-Shu, et al.
Publicado: (2022)

Application of immune checkpoint targets in the anti-tumor novel drugs and traditional Chinese medicine development
por: Wang, Yuli, et al.
Publicado: (2021)

Traditional Chinese medicine in COVID-19
por: Lyu, Ming, et al.
Publicado: (2021)

Formation of a traditional Chinese medicine self-assembly nanostrategy and its application in cancer: a promising treatment
por: Huang, Ju, et al.
Publicado: (2023)

The first Chinese oral anti-COVID-19 drug Azvudine launched
por: Yu, Bin, et al.
Publicado: (2022)

Overview of therapeutic drug research for COVID-19 in China
por: Li, Heng, et al.
Publicado: (2020)

Research progress of traditional Chinese medicine against COVID-19
por: Ren, Wei, et al.
Publicado: (2021)

Advances in the Development of Anti-Haemonchus contortus Vaccines: Challenges, Opportunities, and Perspectives
por: Ehsan, Muhammad, et al.
Publicado: (2020)

New Perspectives on Chinese Herbal Medicine (Zhong-Yao) Research and Development
por: Pan, Si-Yuan, et al.
Publicado: (2011)

Risk Perception and Emotion Reaction of Chinese Health Care Workers Varied During COVID-19: A Repeated Cross-Sectional Research
por: Qianlan, Yin, et al.
Publicado: (2021)

Repurposing Anti-Cancer Drugs for COVID-19 Treatment
por: Borcherding, Nicholas, et al.
Publicado: (2020)

COVID-19 Drug Development
por: Kim, Seungtaek
Publicado: (2022)

Research and Application of Polypropylene Carbonate Composite Materials: A Review
por: Li, Xiangrui, et al.
Publicado: (2022)

Methodology of network pharmacology for research on Chinese herbal medicine against COVID-19: A review
por: Wang, Yi-xuan, et al.
Publicado: (2022)

Development of Cell Lines for use in COVID-19 Drug Development and Research
por: McGill, London
Publicado: (2021)

Union is strength: antiviral and anti-inflammatory drugs for COVID-19
por: Naveja, Jose J., et al.
Publicado: (2021)

Can anti-parasitic drugs help control COVID-19?
por: Panahi, Yasin, et al.
Publicado: (2022)

Research and effectiveness of anti-viral drugs against COVID-19; global public intervention to prevent coronavirus and to improve human health()
por: Alghamdi, Huda Ahmed
Publicado: (2021)

The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
por: Perricone, Carlo, et al.
Publicado: (2020)

Progress in Anti-Mammarenavirus Drug Development
por: Kim, Yu-Jin, et al.
Publicado: (2021)

COVID-19: Discovery, diagnostics and drug development
por: Asselah, Tarik, et al.
Publicado: (2021)

The Historical Development of Deqi Concept from Classics of Traditional Chinese Medicine to Modern Research: Exploitation of the Connotation of Deqi in Chinese Medicine
por: Yuan, Hong-Wen, et al.
Publicado: (2013)

Applications of In Silico Models to Predict Drug-Induced Liver Injury
por: Lin, Jiaying, et al.
Publicado: (2022)

Research in the Field of Drug Design and Development
por: Biala, Grazyna, et al.
Publicado: (2023)

Anti-COVID-19 drug screening: Frontier concepts and core technologies
por: Luo, Hua, et al.
Publicado: (2020)

Effect of interval between food intake and drug administration at fasting condition on the plasma concentrations of first-line anti-tuberculosis drugs in Chinese population
por: Wang, Jun, et al.
Publicado: (2020)

Research Development on Anti-Microbial and Antioxidant Properties of Camel Milk and Its Role as an Anti-Cancer and Anti-Hepatitis Agent
por: Khan, Muhammad Zahoor, et al.
Publicado: (2021)

Molecular mechanism and research progress on pharmacology of traditional Chinese medicine in liver injury
por: Zhang, Hong Yang, et al.
Publicado: (2018)

Translational research in anti-pancreatic fibrosis drug discovery and development
por: Ze, Xingyu, et al.
Publicado: (2021)

Developments in drug delivery of bioactive alkaloids derived from traditional Chinese medicine
por: Zheng, Xiao, et al.
Publicado: (2018)

COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine
por: Guan, Wenyi, et al.
Publicado: (2020)

Chinese Adolescent Research Under COVID-19
por: Shek, Daniel T.L.
Publicado: (2020)

Clinical manifestations of COVID-19 infection in dialysis patients and protective effect of COVID-19 vaccine
por: Zhang, Xuehan, et al.
Publicado: (2023)

Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development
por: Zhu, Yuefei, et al.
Publicado: (2021)

PBPK modeling and simulation in drug research and development
por: Zhuang, Xiaomei, et al.
Publicado: (2016)

Multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines
por: Li, Chuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k9k5ajlm9rtogb9q9rg4pc0fuv